openPR Logo
Press release

Structural Heart Devices Market Insights, Competitive Analysis, Latest Trends, And Forecast To 2033

Structural Heart Devices Market Insights

Structural Heart Devices Market Insights

"The Business Research Company recently released a comprehensive report on the Global Structural Heart Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The structural heart devices market size has grown strongly in recent years. It will grow from $9.5 billion in 2023 to $10.4 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, growing patient preference for non-surgical or minimally invasive treatment options.

The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $15.06 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increasing adoption of transcatheter valve replacement, ongoing development of innovative devices with advanced materials, growing emphasis on personalized treatment approaches, increasing adoption of hybrid procedures, integration of remote monitoring and telehealth solutions.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Market Drivers and Trends:

The rising prevalence of cardiovascular diseases is expected to propel the growth of the structural heart device market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, and strokes. The cases of cardiovascular diseases, including heart disease and stroke, have been steadily increasing globally due to sedentary lifestyles, poor dietary habits, rising obesity rates, smoking, and aging populations. Structural heart devices treat cardiovascular diseases by repairing or replacing damaged heart valves, correcting structural defects, and improving heart function and patient outcomes. For instance, in January 2024, according to a report published by the American Heart Association, a US-based nonprofit organization focused on cardiovascular medical research, cardiovascular disease caused 931,578 deaths in the US, slightly more than the 928,741 in 2020. Globally, there were 19.91 million CVD deaths in 2021, compared to 19.05 million in 2020. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the structural heart device market.

Major companies operating in the structural heart devices market are developing minimally invasive treatment procedures and devices to enhance patient outcomes, reduce recovery times, and expand treatment options for structural heart conditions. A self-expanding transcatheter aortic valve implantation (TAVI) system is a device designed to deploy and secure the replacement valve within the native aortic valve anatomy without relying on balloon inflation. For instance, in December 2022, Abbott Laboratories, a US-based company manufacturing medical devices and health care products, launched the latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, in India. It is tailored for individuals with severe aortic stenosis at high or extreme surgical risk and features advancements such as a unique design to prevent valve leakage. Navitor enhances Abbott's structural heart transcatheter portfolio, offering physicians and patients minimally invasive treatment options for heart diseases. It stands out as the sole self-expanding TAVI system with intra-annular leaflets and large frame cells, facilitating improved access to coronary arteries for potential future interventions in coronary artery disease (CAD). This new design also enhances hemodynamics, optimizing blood flow.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

Major Key Players of the Market:

Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

Structural Heart Devices Market 2024 Key Insights:

• The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $15.06 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%.
• Rising Prevalence Of Cardiovascular Diseases And The Structural Heart Device Market
• Advancements In Minimally Invasive Repair Devices For Structural Heart Conditions
• North America was the largest region in the structural heart devices market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15677&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Structural Heart Devices Market Insights, Competitive Analysis, Latest Trends, And Forecast To 2033 here

News-ID: 3705602 • Views:

More Releases from The Business Research Company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for Heart

Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health. Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease. Top Heart Healthy Foods Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after